Back to Search Start Over

Hydroxytyrosol nicotinate, a new multifunctional hypolipidemic and hypoglycemic agent.

Authors :
Xie YD
Chen ZZ
Li N
Lu WF
Xu YH
Lin YY
Shao LH
Wang QT
Guo LY
Gao YQ
Yang GD
Li YP
Bian XL
Source :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2018 Mar; Vol. 99, pp. 715-724. Date of Electronic Publication: 2018 Feb 20.
Publication Year :
2018

Abstract

Hydroxytyrosol (HT) is a natural polyphenol antioxidant that exists in olive oil. In the study of multifunctional hypolipidemic of nicotinic derivatives, we found that hydroxytyrosol nicotinate (HT-N) incorporation of niacin with HT displayed ?-glucosidase inhibitory activities in vitro, such as yeast ?-glucosidase (IC <subscript>50</subscript> ?=?117.72??M) and rat intestinal ?-glucosidases maltase (IC <subscript>50</subscript> ?=?31.86??M) and sucrase (IC <subscript>50</subscript> ?=?22.99??M), and had a good control of postprandial blood glucose (PBG). HT-N shown significantly hypoglycemic action by 16.9% and protection of pancreatic tissue in type 2 diabetic mellitus (T2DM) mouse model. HT-N also shown a potent antioxidant activity and property of anti-glycation in vitro, which were benefit for ameliorating diabetic complications. Moreover, HT-N exhibited much significant hypolipidemia, lowering plasma triglyceride (TG), total cholesterol (TC), and malonaldehyde (MDA) by 34.6%, 45.8% and 32.1% respectively, in hyperlipidemic mice induced by Triton WR 1339. The results indicated that HT-N has hypolipidemic, hypoglycemic and antioxidant actions. All these properties could be conducive to amelioration of oxidative stress, hyperlipidemia, and diabetes that HT-N may serve as a multifunctional potential therapeutic strategy in diabetic patients with hyperlipidemia.<br /> (Copyright © 2018 Elsevier Masson SAS. All rights reserved.)

Details

Language :
English
ISSN :
1950-6007
Volume :
99
Database :
MEDLINE
Journal :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publication Type :
Academic Journal
Accession number :
29710469
Full Text :
https://doi.org/10.1016/j.biopha.2018.01.123